Home > Drug Search >
  • company_query: Acacia
  •   > 
Drug Filter
Category:
chemistry (9) biology (21)
Status:
Approved (5) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (14) Phase Ⅰ (7)
Clinical Stage:
Pending (3) Active (14) Discontinued (8)
Bio-Type:
Gene therapy (2) Cell therapy (3) Vaccine (3) Blood extraction (1) Microbial extract (1) Recombinant enzyme (1) Recombinant cytokines (7) Whole antibody (2) Fusion protein (1)
Indication:
Acute coronary syndrome (ACS) (1) Acute myeloid Leukemia (AML) (1) Anemia (1) Attention deficit hyperactivity disorder (ADHD) (1) Bladder cancer (1) Cystic fibrosis (CF) (1) Depression (2) Erectile dysfunction (ED) (2) Urogenital cancer (1) HBV infection (2) HCV infection (2) HIV infection (1) Hyperuricemia (1) Major depressive disorder (MDD) (1) Melanoma (2) Multiple myeloma (MM) (2) Osteoarthritis (OA) (1) Ovarian cancer (1) Pneumonia (1) Postoperative nausea and vomiting (1) Prostate cancer (1) Dupuytren's contracture (1) Peyronie's disease (1) Botulism (1) Schizophrenia (1) Ulcerative colitis (2) Dysentery (1) Diabetic foot ulcers (1) Stroke (1) Malaria (1) Neutropenia (2) Spinal cord injury (1) Sepsis (1) Staphylococcal infection (1) Brain injury (1) Liposarcoma (1) Plaque psoriasis (1) Mesothelioma (1) Ebola virus disease (EVD) (1) Chronic fatigue syndrome (1) Gastrointestinal cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top